MedPath

TO COMPARE HEMODYNAMIC PARAMETER AND POST-OPERATIVE ANALGESIA OF KETAMINE AND MAGNESIUM SULPHATE IN PRE-EMPTIVE DOSES IN PATIENT UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY UNDER GENERAL ANAESTHESIA

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/12/048059
Lead Sponsor
SIKKIM MANIPAL INSTITUTE OF MEDICAL SCIENCES
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. American society of Anaesthesiology score [ASA] I and 2

2. Age between 18 years and 65 years

3. Surgery lasting between 60 to 90 mins

4. Laparoscopic cholecystectomy using four ports

Exclusion Criteria

Patient refusal

2. Any systemic co-morbidity including uncontrolled hypertension and

diabetes, Heart block, renal impairment (serum creatinine greater than

2mg/dl, hepatic impairment (trans-aminases greater than double the

normal values), psychiatric disorders like Schizophrenia and Mania

3. Patient on any addictive drug or allergic to any drug used in the trial

4. Pregnant patient and lactating mothers

5. Glaucoma, raised intracranial pressure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
KETAMINE IS SUPERIOR TO MAGNESIUM SULPHATE AS IT PROVIDE BETTER INTRA-OPERATIVE AND POST-OPERATIVE ANALGESIA AND IT DELAYS THE TIME FOR THE FIRST RESCUE ANALGESIA REQUEST.Timepoint: Patient wll be monitored for post-operative analgesia for 24 hrs.
Secondary Outcome Measures
NameTimeMethod
changes in hemodynamic parameterTimepoint: hemodynamic parameters will be monitored for 60 mins
© Copyright 2025. All Rights Reserved by MedPath